{"id":45979,"date":"2022-07-08T16:01:47","date_gmt":"2022-07-08T14:01:47","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/mindmaze-receives-recognition-as-one-of-switzerlands-best-managed-companies\/"},"modified":"2022-07-08T16:01:47","modified_gmt":"2022-07-08T14:01:47","slug":"mindmaze-receives-recognition-as-one-of-switzerlands-best-managed-companies","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/mindmaze-receives-recognition-as-one-of-switzerlands-best-managed-companies\/","title":{"rendered":"MindMaze Receives Recognition as one of Switzerland\u2019s Best Managed Companies"},"content":{"rendered":"
\n

LAUSANNE, Switzerland–(BUSINESS WIRE)–MindMaze, a global pioneer in neurotechnology and digital therapeutics (DTx) for neurological recovery and care, has been recognized as one of Switzerland\u2019s Best Managed Companies in 2022. This programme, sponsored by Deloitte Private, SIX Swiss Exchange, and Julius Baer, awards Swiss companies who operate at the highest level of business performance.\n<\/p>\n

<\/a><\/p>\n

\n\u201cWe are thrilled to receive this distinguished recognition for our efforts,\u201d said COO of MindMaze, Jean-Marc Wismer. \u201cAs a team we are focused on innovation and quality because when it comes to developing groundbreaking technologies and therapies to treat those suffering from neurological conditions and injuries, good business practices and processes are vital to attract and retain great talent and grow sustainably.\u201d\n<\/p>\n

\nSwitzerland\u2019s Best Managed Companies Programme<\/a> highlights exceptional business practices executed by Switzerland\u2019s best privately owned companies. A company\u2019s efforts, overall growth, and management abilities factor into the programme\u2019s selection. The Deloitte evaluation for these awards is based on 29 years of observed practice from the global awards programme that has been rolled out in 48 countries worldwide. Companies that are chosen for this award are upheld as examples for other businesses to follow.\n<\/p>\n

\nThe company\u2019s unique organizational model supports both rapid scalability and allows for greater flexibility in a changing environment. This model has proven to be highly effective particularly through COVID, enabling the company to seamlessly adapt its business model to balance product development, marketing and sales activities and maintain strong revenue growth with continued expansion of commercial operations across 15 countries. \u201cDeloitte\u2019s recognition further validates our agile governance hierarchy, which focuses on roles instead of titles,\u201d adds Wismer. \u201cCultivating an atmosphere of collaboration and accountability has allowed us to form efficient and ethical business practices that benefit the company, its employees, and our stakeholders.\u201d\n<\/p>\n

\nAbout MindMaze<\/b>\n<\/p>\n

\nFounded in 2012, MindMaze is a global leader in brain technology and digital neurotherapeutic solutions for brain health and recovery. Its mission is to accelerate the brain\u2019s ability to recover, learn and adapt. The company has two core divisions \u2013 Healthcare and Labs \u2013 working collaboratively at the intersection of neuroscience, bio-sensing, engineering, mixed reality and artificial intelligence. MindMaze Healthcare is advancing a universal platform for brain health with breakthrough solutions to some of the world\u2019s most challenging problems in neurology, including stroke, Parkinson\u2019s disease and Alzheimer\u2019s disease. MindMaze Labs, the company\u2019s R&D innovation hub, is focused on the future of human computing \u2013 working across multiple industries to innovate and build the next generation of human-machine interfaces. The company has offices in Lausanne, Baltimore, London, Paris and Mumbai. For more information, please visit www.mindmaze.com<\/a>.\n<\/p>\n

Contacts<\/b> <\/p>\n

\nMindMaze
\n
Public Relations
\n
Phoebe Alix
\n
E: pr@mindmaze.com<\/a>\n<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

LAUSANNE, Switzerland–(BUSINESS WIRE)–MindMaze, a global pioneer in neurotechnology and digital therapeutics (DTx) for neurological recovery and care, has been recognized as one of Switzerland\u2019s Best Managed Companies in 2022. This programme, sponsored by Deloitte Private, SIX Swiss Exchange, and Julius Baer, awards Swiss companies who operate at the highest level of business performance. \u201cWe are … [Read more…]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-45979","6":"format-standard","7":"category-industry"},"yoast_head":"\nMindMaze Receives Recognition as one of Switzerland\u2019s Best Managed Companies - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/mindmaze-receives-recognition-as-one-of-switzerlands-best-managed-companies\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"MindMaze Receives Recognition as one of Switzerland\u2019s Best Managed Companies - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"LAUSANNE, Switzerland–(BUSINESS WIRE)–MindMaze, a global pioneer in neurotechnology and digital therapeutics (DTx) for neurological recovery and care, has been recognized as one of Switzerland\u2019s Best Managed Companies in 2022. This programme, sponsored by Deloitte Private, SIX Swiss Exchange, and Julius Baer, awards Swiss companies who operate at the highest level of business performance. \u201cWe are ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/mindmaze-receives-recognition-as-one-of-switzerlands-best-managed-companies\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2022-07-08T14:01:47+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20220708005284\/en\/1468657\/21\/MindMaze-Logo-432-Pos.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/mindmaze-receives-recognition-as-one-of-switzerlands-best-managed-companies\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/mindmaze-receives-recognition-as-one-of-switzerlands-best-managed-companies\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"MindMaze Receives Recognition as one of Switzerland\u2019s Best Managed Companies\",\"datePublished\":\"2022-07-08T14:01:47+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/mindmaze-receives-recognition-as-one-of-switzerlands-best-managed-companies\\\/\"},\"wordCount\":459,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/mindmaze-receives-recognition-as-one-of-switzerlands-best-managed-companies\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220708005284\\\/en\\\/1468657\\\/21\\\/MindMaze-Logo-432-Pos.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/mindmaze-receives-recognition-as-one-of-switzerlands-best-managed-companies\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/mindmaze-receives-recognition-as-one-of-switzerlands-best-managed-companies\\\/\",\"name\":\"MindMaze Receives Recognition as one of Switzerland\u2019s Best Managed Companies - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/mindmaze-receives-recognition-as-one-of-switzerlands-best-managed-companies\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/mindmaze-receives-recognition-as-one-of-switzerlands-best-managed-companies\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220708005284\\\/en\\\/1468657\\\/21\\\/MindMaze-Logo-432-Pos.jpg\",\"datePublished\":\"2022-07-08T14:01:47+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/mindmaze-receives-recognition-as-one-of-switzerlands-best-managed-companies\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/mindmaze-receives-recognition-as-one-of-switzerlands-best-managed-companies\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/mindmaze-receives-recognition-as-one-of-switzerlands-best-managed-companies\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220708005284\\\/en\\\/1468657\\\/21\\\/MindMaze-Logo-432-Pos.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220708005284\\\/en\\\/1468657\\\/21\\\/MindMaze-Logo-432-Pos.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/mindmaze-receives-recognition-as-one-of-switzerlands-best-managed-companies\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"MindMaze Receives Recognition as one of Switzerland\u2019s Best Managed Companies\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"MindMaze Receives Recognition as one of Switzerland\u2019s Best Managed Companies - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/mindmaze-receives-recognition-as-one-of-switzerlands-best-managed-companies\/","og_locale":"en_US","og_type":"article","og_title":"MindMaze Receives Recognition as one of Switzerland\u2019s Best Managed Companies - Pharma Trend","og_description":"LAUSANNE, Switzerland–(BUSINESS WIRE)–MindMaze, a global pioneer in neurotechnology and digital therapeutics (DTx) for neurological recovery and care, has been recognized as one of Switzerland\u2019s Best Managed Companies in 2022. This programme, sponsored by Deloitte Private, SIX Swiss Exchange, and Julius Baer, awards Swiss companies who operate at the highest level of business performance. \u201cWe are ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/mindmaze-receives-recognition-as-one-of-switzerlands-best-managed-companies\/","og_site_name":"Pharma Trend","article_published_time":"2022-07-08T14:01:47+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20220708005284\/en\/1468657\/21\/MindMaze-Logo-432-Pos.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/mindmaze-receives-recognition-as-one-of-switzerlands-best-managed-companies\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/mindmaze-receives-recognition-as-one-of-switzerlands-best-managed-companies\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"MindMaze Receives Recognition as one of Switzerland\u2019s Best Managed Companies","datePublished":"2022-07-08T14:01:47+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/mindmaze-receives-recognition-as-one-of-switzerlands-best-managed-companies\/"},"wordCount":459,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/mindmaze-receives-recognition-as-one-of-switzerlands-best-managed-companies\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20220708005284\/en\/1468657\/21\/MindMaze-Logo-432-Pos.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/mindmaze-receives-recognition-as-one-of-switzerlands-best-managed-companies\/","url":"https:\/\/pharma-trend.com\/en\/mindmaze-receives-recognition-as-one-of-switzerlands-best-managed-companies\/","name":"MindMaze Receives Recognition as one of Switzerland\u2019s Best Managed Companies - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/mindmaze-receives-recognition-as-one-of-switzerlands-best-managed-companies\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/mindmaze-receives-recognition-as-one-of-switzerlands-best-managed-companies\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20220708005284\/en\/1468657\/21\/MindMaze-Logo-432-Pos.jpg","datePublished":"2022-07-08T14:01:47+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/mindmaze-receives-recognition-as-one-of-switzerlands-best-managed-companies\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/mindmaze-receives-recognition-as-one-of-switzerlands-best-managed-companies\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/mindmaze-receives-recognition-as-one-of-switzerlands-best-managed-companies\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20220708005284\/en\/1468657\/21\/MindMaze-Logo-432-Pos.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20220708005284\/en\/1468657\/21\/MindMaze-Logo-432-Pos.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/mindmaze-receives-recognition-as-one-of-switzerlands-best-managed-companies\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"MindMaze Receives Recognition as one of Switzerland\u2019s Best Managed Companies"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/45979","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=45979"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/45979\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=45979"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=45979"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=45979"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}